Safety Analysis of Simultaneous Vaccination of Japanese Encephalitis Attenuated Live Vaccine and Measles, Mumps, and Rubella Combined Attenuated Live Vaccine from 2020 to 2023 in Guangzhou, China

Safety Analysis of Simultaneous Vaccination of Japanese Encephalitis Attenuated Live Vaccine and Measles, Mumps, and Rubella Combined Attenuated Live Vaccine from 2020 to 2023 in Guangzhou, China

Objectives: Our objectives were to evaluate the safety of the simultaneous vaccination of Japanese encephalitis attenuated live vaccine (JEV-L) and measles, mumps, and rubella combined attenuated live vaccine (MMR) in children and to provide a reference for the implementation of the strategy of simu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jie Liu, Yong Huang, Fengrui Jing, Yan Kang, Qiaojuan Liu, Zhiwei Zheng, Chunhuan Zhang, Xiaofeng Liang, Zhoubin Zhang
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Vaccines
Subjects:	Japanese encephalitis attenuated live vaccine Measles-mumps-rubella vaccine measles, mumps, and rubella combined attenuated live vaccine simultaneous vaccination safety adverse reaction
Online Access:	https://www.mdpi.com/2076-393X/13/4/417
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Combination Vaccine against Measles
by: M. P. Kostinov
Published: (2020-09-01)

Impact of Measles, Mumps, and Rubella Vaccination on Hospitalizations and Human Capital: Evidence from Copenhagen School Health Records
by: Onur Altindag, et al.
Published: (2025-03-01)

Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024
by: Anna Y. Popova, et al.
Published: (2025-06-01)

Impact of vaccination strategy adjustments on antibody levels against measles, rubella, mumps, and varicella in China: a single-center serological survey
by: Zhixin Geng, et al.
Published: (2025-08-01)

Measles, mumps and rubella vaccination coverage in capitals and interior region municipalities of Northeast Brazil: a household survey in a cohort of children born in 2017 and 2018
by: Adjoane Mauricio Silva Maciel, et al.
Published: (2024-12-01)

Serological status of measles, mumps, and rubella antibodies in HIV-positive women of childbearing age at a referral hospital in Iran
by: Sara Ghaderkhani, et al.
Published: (2025-04-01)

Domestic Tetravaccine (Measles-Rubella-Mumps) – Immunization of Premature Babies
by: V. V. Semerikov, et al.
Published: (2022-09-01)

A Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts
by: Bibisha Baaniya, et al.
Published: (2025-05-01)

Vaccination coverage, delay and loss to follow-up of the triple viral vaccine, in live births between 2017 and 2018 in Brazilian cities
by: Tatiana Lang D’Agostini, et al.
Published: (2024-12-01)

Measles， rubella， and mumps antibody seroprevalence among the children aged 18 years and younger in Karamay City， Xinjiang Uygur Autonomous Region
by: WU Meili, et al.
Published: (2025-03-01)

Methicillin-resistant Staphylococcus Aureus Bacteraemia in a Young Boy following Mumps Infection: A Case Report
by: Jayakanthan Saravanan, et al.
Published: (2025-01-01)

Collective Immunity to the Measles, Mumps, and Rubella Viruses in the Kyrgyz Population
by: Anna Yurievna Popova, et al.
Published: (2025-02-01)

STATE OF MEASLES, RUBELLA AND MUMPS IN THE SARATOV REGION IN 2001—2013 YEARS
by: T. N. Buchkova, et al.
Published: (2015-08-01)

Preventive Efficacy, Safety, Immunogenic Activity, and Evaluation of Post-Vaccination Responses Following Immunization with Combined Trivalent Vaccine Vaktrivir (Measles-Rubella-Parotitis) in Premature Infants
by: Vadislav V. Semerikov, et al.
Published: (2024-05-01)

Topical issues of vaccination and epidemiological surveillance over measles and rubella in Ukraine.
by: G. M. Daragan, et al.
Published: (2018-04-01)

A Comparative Study of the Efficacy of Intralesional Measles Mumps Rubella (MMR) Vaccine and Auto Implantation for the Treatment of Periungual and Palmoplantar Warts: A Randomized Controlled Trial
by: Ravindra Abusaria, et al.
Published: (2024-08-01)

The main factors, associated with incomplete vaccination againts measels, parotitis, rubella, and diphtheria in 170 juvenile idiopathic arthritis patients: the results of prospective pilot study
by: N. A. Lybimova, et al.
Published: (2021-07-01)

Seroprevalence against measles, Austria, stratified by birth years 1922 to 2024
by: Lukas Weseslindtner
Published: (2025-04-01)

Characteristics of the epidemic process of measles, rubella and mumps in Moscow and assessment of their seroprevalence at the present stage
by: Yana V. Simakova, et al.
Published: (2025-04-01)

Prematurely Born Children: Vaccination – Safety and Specific Immune Response
by: S. M. Kharit, et al.
Published: (2015-08-01)

Seroprevalence of Measles-, Mumps-, and Rubella-Specific Antibodies in Future Healthcare Workers in Serbia: A Cross-Sectional Study
by: Ana Banko, et al.
Published: (2025-06-01)

Immunological Protection Against Vaccine-Preventable Infections (Hepatitis B, Measles, Rubella, Mumps, Diphtheria, Tetanus) of Russian and Foreign Students: A Simultaneous Study
by: Diana V. Sutovskaya, et al.
Published: (2020-02-01)

Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir<sup>®</sup> in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)
by: I. V. Feldblium, et al.
Published: (2021-03-01)

Seroprevalence of Measles, Rubella and Mumps Antibodies in Foreign Citizens Registered in Moscow Region (Labour Migrants)
by: T. A. Semenenko, et al.
Published: (2017-06-01)

ENHANCING KNOWLEDGE AND AWARENESS FOR MEASLES AND RUBELLA ELIMINATION TO PREVENT CONGENITAL RUBELLA SYNDROME IN KULON PROGO AND GUNUNGKIDUL REGENCIES
by: Elisabeth Siti Herini, et al.
Published: (2024-11-01)

Effectiveness and Immunogenicity of the MMR Vaccine Against SARS-CoV-2 Among Healthcare Workers
by: Hyeri Seok, et al.
Published: (2025-02-01)

Sustaining measles and rubella elimination through the Regional Monitoring and Re-Verification Commission in the Americas
by: Jon K. Andrus, et al.
Published: (2024-12-01)

Assessment of the Coverage and Timeliness of Immunization against Selected Vaccine-Preventable Infections in Children in Russia in 2019–2022
by: I. V. Kocheshkova, et al.
Published: (2025-03-01)

Coverage and predictors of full measles-rubella immunization among children aged 24–59 months in Northern Ghana: a post measles outbreak assessment
by: Abdul Gafaru Mohammed, et al.
Published: (2025-05-01)

Safety of antibodies to measles, mumps, rubella and diphtheria in patients with juvenile idiopathic arthritis
by: I. V. Fridman, et al.
Published: (2021-07-01)

Experiences and Lessons Learned from the Measles-Rubella Vaccination Campaign 2023 Implemented in Private Schools of Kolkata
by: Poulomi Mukherjee, et al.
Published: (2025-07-01)

Lessons for sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Caribbean
by: Tracy Evans-Gilbert, et al.
Published: (2024-12-01)

Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations
by: Darin Zehrung, et al.
Published: (2024-11-01)

Global challenges and solutions to achieving and sustaining measles and rubella elimination
by: Natasha S. Crowcroft, et al.
Published: (2024-12-01)

The Health and Economic Benefits of United States Investments in Measles and Rubella Control and Elimination
by: Kimberly M. Thompson
Published: (2024-10-01)

Monitoring the quality of domestic measles prevention vaccines
by: A. S. Binyatova, et al.
Published: (2021-05-01)

Manifestations of the Epidemic Process of Measles and Rubella at the Present Stage
by: A. A. Pozdnyakov, et al.
Published: (2018-10-01)

Timing of Measles, Mumps, and Rubella Vaccination: Secondary Outcomes from an Immunological Survey
by: Jana Zibolenová, et al.
Published: (2025-04-01)

Viral Live‐Attenuated Vaccines (LAVs): Past and Future Directions
by: Yan‐Dong Tang, et al.
Published: (2025-01-01)

Preservation of Antibodies to Vaccine-Controlled Infections in Children WITH Oncological Diseases
by: S. M. Kharit, et al.
Published: (2023-09-01)